Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results From the Phase 2b Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome

被引：0
|
作者：
Gilbert, D. L.
Karkanias, G. B.
Atkinson, S. D.
Munschauer, F.
Wanaski, S.
Cunniff, T.
机构：
来源：
ANNALS OF NEUROLOGY | 2025年 / 96卷
关键词：
Experimental Therapeutics; Movement Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
97
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [41] A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
    Lorcan McGarvey
    Jaclyn A. Smith
    Alyn Morice
    Surinder S. Birring
    Kian Fan Chung
    Peter V. Dicpinigaitis
    Akio Niimi
    Michael S. Benninger
    Mandel Sher
    Yuko Matsunaga
    Sayaka Miyazaki
    Mitsuaki Machida
    Hiroyuki Ishihara
    Adnan Mahmood
    Juan-Carlos Gomez
    Lung, 2023, 201 : 25 - 35
  • [42] The Effect of Panax ginseng on Genitourinary Syndrome in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Ghorbani, Zahra
    Mirghafourvand, Mojgan
    Farshbaf Khalili, Azizeh
    Javadzadeh, Yousef
    Shakouri, Seyed Kazem
    Dastranj Tabrizi, Ali
    COMPLEMENTARY MEDICINE RESEARCH, 2021, 28 (05) : 419 - 426
  • [43] Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
    Jordi Bruna
    Sebastián Videla
    Andreas A. Argyriou
    Roser Velasco
    Jesús Villoria
    Cristina Santos
    Cristina Nadal
    Guido Cavaletti
    Paola Alberti
    Chiara Briani
    Haralabos P. Kalofonos
    Diego Cortinovis
    Mariano Sust
    Anna Vaqué
    Thomas Klein
    Carlos Plata-Salamán
    Neurotherapeutics, 2018, 15 : 178 - 189
  • [44] Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
    Bruna, Jordi
    Videla, Sebastian
    Argyriou, Andreas A.
    Velasco, Roser
    Villoria, Jesus
    Santos, Cristina
    Nadal, Cristina
    Cavaletti, Guido
    Alberti, Paola
    Briani, Chiara
    Kalofonos, Haralabos P.
    Cortinovis, Diego
    Sust, Mariano
    Vaque, Anna
    Klein, Thomas
    Plata-Salaman, Carlos
    NEUROTHERAPEUTICS, 2018, 15 (01) : 178 - 189
  • [45] Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial
    Pignolo, Robert J.
    Baujat, Genevieve
    Hsiao, Edward C.
    Keen, Richard
    Wilson, Amy
    Packman, Jeff
    Strahs, Andrew L.
    Grogan, Donna R.
    Kaplan, Frederick S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (10) : 1891 - 1902
  • [46] Treatment with the histamine 1 receptor antagonist ebastine for non-constipated irritable bowel syndrome: A double-blind randomized placebo-controlled trial
    Decraecker, L.
    De Looze, D.
    Hirsch, D.
    De Schepper, H.
    Arts, J.
    Caenepeel, P.
    Bredenoord, A. J.
    Vanuytsel, T.
    Belmans, A.
    Boeckxstaens, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
  • [47] DESIGN OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL OF THE TOLL-LIKE RECEPTOR ANTAGONIST IMO-8400 IN PATIENTS WITH DERMATOMYOSITIS
    Gordon, P.
    Cooper, R.
    Chinoy, H.
    Isenberg, D.
    Lundberg, I. E.
    Werth, V.
    Gruis, K.
    Hurtt, M.
    Brevard, J.
    Granlund, L.
    Fiorentino, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1119 - 1119
  • [48] TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Decraecker, Lisse
    Pia, Fedrica
    De Looze, Danny
    Hirsch, David
    De Schepper, Heiko U.
    Arts, Joris
    Caenepeel, Philip
    Bredenoord, Arjan
    Vanuytsel, Tim
    Belmans, Ann
    Boeckxstaens, Guy
    GASTROENTEROLOGY, 2024, 166 (05) : S53 - S53
  • [49] Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double-blind, placebo-controlled trial
    Viscusi, Eugene R.
    Torjman, Marc C.
    Munera, Catherine L.
    Stauffer, Joseph W.
    Setnik, Beatrice S.
    Bagal, Sukirti N.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (05): : 1886 - 1893
  • [50] TREATMENT OF PREMENSTRUAL-SYNDROME WITH ALPRAZOLAM - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CROSSOVER CLINICAL-TRIAL
    SMITH, S
    RINEHART, JS
    RUDDOCK, VE
    SCHIFF, I
    OBSTETRICS AND GYNECOLOGY, 1987, 70 (01): : 37 - 43
12345